OS Therapies Incorporated (OSTX)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	126.03M
Revenue (ttm)	n/a
Net Income (ttm)	-6.38M
Shares Out	25.21M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About OSTX

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults. Our pipeline includes two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 3
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: OSTX